NCT03108755View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and Elderly Subjects and Healthy Japanese Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 23, 2017

Primary Completion Date

August 25, 2017

Study Completion Date

August 25, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

ASP7713

oral

DRUG

Placebo

oral

Trial Locations (1)

HA 1 3UJ

Site GB44001, Harrow

All Listed Sponsors
lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT03108755 - A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and Elderly Subjects and Healthy Japanese Adult Subjects | Biotech Hunter | Biotech Hunter